- Hallucinations in Parkinson's disease: prevalence, phenomenology and risk factorsG Fenelon
Department of Neurology, Hopital Tenon, Paris, France
Brain 123:733-45. 2000..The main risk factor in treated patients is cognitive impairment, although sleep-wake cycle disturbances, and possibly other factors related to the duration of the disease, act as cofactors...
- Patient profile, indications, efficacy and safety of duodenal levodopa infusion in advanced Parkinson's diseaseDavid Devos
Department of Neurology, EA2683 IFR114 IMPRT, Hopital R Salengro, CHU Lille, France
Mov Disord 24:993-1000. 2009..Technical problems were commonplace. Duodenal levodopa infusion seems to be an effective last-line therapy for motor complications in Parkinson's disease. Hence, technical improvements and earlier introduction should be considered...